Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06274034 · ClinicalTrials.gov registry record · Early Phase 1

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

A Early Phase 1 study of Breast Carcinoma, sponsored by Mayo Clinic.

Recruiting
Registry status
Early Phase 1
Development phase
40
Enrollment target
1
Study location

NCT06274034 is a Early Phase 1 study of Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06274034, a Early Phase 1 study of Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This early phase I trial evaluates the feasibility and impact of a meditation headband system (MUSE-S) for breast cancer survivors. Anxiety and insomnia are among the most common distresses in breast cancer survivors during and after chemotherapy, in part due to the side effects of chemotherapy, fear of cancer coming back, progression of the cancer, and uncertainty of the future. These distresses impair patients' well-being and quality of life (QOL) in general, and their cancer treatment adherence and effectiveness in particular. Meditation has been demonstrated to be an effective management tool of stress and anxiety and is given the highest level of evidence (grade A) in the systematic review-based guidelines by the Society of Integrative Medicine. The portable, interactive, electroencephalographic (EEG) Muse headband guided meditation has been shown to improve fatigue, QOL, and stress in newly diagnosed breast cancer patients. The MUSE-S Headband System may decrease anxiety and insomnia among breast cancer survivors.

Conditions Studied

Breast Carcinoma

Interventions

  • OTHER Survey Administration
  • OTHER Medical Device Usage and Evaluation
  • OTHER Electronic Health Record Review
  • PROCEDURE Meditation Therapy

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-08
Est. Completion 2029-01-31
Phase Early Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06274034

The ClinicalTrials.gov registry entry for NCT06274034 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.

NCT06274034 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06274034 about?

NCT06274034 is a clinical study titled "MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors". This early phase I trial evaluates the feasibility and impact of a meditation headband system (MUSE-S) for breast cancer survivors. Anxiety and insomnia are among the most common distresses in breast cancer survivors during and after chemotherapy, in part due to the side effects of chemotherapy, fea...

What is the current status of trial NCT06274034?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2024-01-08. Estimated completion is 2029-01-31.

What conditions does trial NCT06274034 study?

This clinical trial studies the following conditions: Breast Carcinoma.

What interventions are being tested in trial NCT06274034?

The interventions under investigation include: Survey Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Electronic Health Record Review (OTHER), Meditation Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT06274034?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06274034 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Carcinoma

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.